Daily News Podcast

A hidden bonus for rivaroxaban?

Publish date: September 24, 2018

 

Bleeding from rivaroxaban may help diagnose some GI and GU cancers. Also today, a review by the FDA supports the safety of nuplazid, arthritis is prevalent in older adults with any degree of depression, and growth in overdose deaths is exponential.

Amazon Alexa
Apple Podcasts
Spotify

Recommended Reading

ATTR-ACT shows treatment breakthrough in amyloid cardiomyopathy
MDedge Neurology
Modest alcohol and NAFLD
MDedge Neurology
Cardiovascular risk with diclofenac
MDedge Neurology
Baloxavir, oseltamivir similar for influenza
MDedge Neurology
New guidelines on prophylaxis for cancer-related immunosuppresion
MDedge Neurology
Urine drug screens show improper medication use
MDedge Neurology
Alarming rate of diabetes medication discontinuations
MDedge Neurology
Troubling MRI changes and pediatric hypertension
MDedge Neurology
Behavioral intervention in obese adults
MDedge Neurology
What you should know about celiac disease
MDedge Neurology